Khan DA, et al. Drug allergy: a 2022 practice parameter update. J Allergy Clin Immunol. 2022. https://doi.org/10.1016/j.jaci.2022.08.028.

Article  PubMed  PubMed Central  Google Scholar 

Pichler WJ. Immune pathomechanism and classification of drug hypersensitivity. Allergy: Eur J Allergy Clin Immunol. Blackwell Publishing Ltd. 2019;74(8):1457–71. https://doi.org/10.1111/all.13765.

Schmid O, Bereznicki B, Peterson GM, Stankovich J, Bereznicki L. Persistence of adverse drug reaction-related hospitalization risk following discharge. Int J Environ Res Public Health. 2022;19(9). https://doi.org/10.3390/ijerph19095585.

Forster AJ, Jennings A, Chow C, Leeder C, van Walraven C. A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc. 2012;19(1):31–8. https://doi.org/10.1136/amiajnl-2011-000454.

Article  PubMed  PubMed Central  Google Scholar 

Ball R, Robb M, Anderson SA, Dal Pan G. The FDAs sentinel initiative—a comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2016;99(3):265–8. Nature Publishing Group. https://doi.org/10.1002/cpt.320.

Kwan JL, et al. Computerised clinical decision support systems and absolute improvements in care: meta-analysis of controlled clinical trials. BMJ. 2020;370. https://doi.org/10.1136/bmj.m3216.

Goss FR, Plasek JM, Lau JJ, Seger DL, Chang FY, Zhou L. An evaluation of a natural language processing tool for identifying and encoding allergy information in emergency department clinical notes. AMIA Annu Symp Proc. 2014;2014:580–8.

PubMed  PubMed Central  Google Scholar 

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients a meta-analysis of prospective studies. [Online]. https://jamanetwork.com/.

Iammatteo M, et al. Identifying allergic drug reactions through placebo-controlled graded challenges, J Allergy Clin Immunol. In Pract. 2017;5(3):711-717.e2. https://doi.org/10.1016/j.jaip.2016.09.041.

Article  Google Scholar 

Iammatteo M, et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing, J Allergy Clin Immunol. In Pract. 2019;7(1):236–43. https://doi.org/10.1016/j.jaip.2018.05.008.

Article  Google Scholar 

Zhou L, et al. Drug allergies documented in electronic health records of a large healthcare system. Allergy: Eur J Allergy Clin Immunol. 2016;71(9):1305–13. https://doi.org/10.1111/all.12881.

Wang L, et al. A dynamic reaction picklist for improving allergy reaction documentation in the electronic health record. J Am Med Inform Assoc. 2020;27(6):917–23. https://doi.org/10.1093/jamia/ocaa042.

Article  PubMed  PubMed Central  Google Scholar 

Ho T-B, Le L, Thai DT, Taewijit S. Data-driven approach to detect and predict adverse drug reactions. Curr Pharm Des. 2016;22:3498–526. [Online]. https://www.nlm.nih.gov/bsd/pmresources.html.

Bailey C, et al. Adverse drug event reporting systems: a systematic review. Br J Clin Pharmacol. Blackwell Publishing Ltd. 2016:17–29. https://doi.org/10.1111/bcp.12944.

•• Bassir F, Varghese S, Wang L, Chin YP, Zhou L. The use of electronic health records to study drug-induced hypersensitivity reactions from 2000 to 2021: a systematic review. Immunol Allergy Clin. 2022;42(2):453–97. Systematic review of EHR use in drug allergy research from 2000 to 2021 highlights the need to improve clinical documentation and CDS alerting to enhance patient safety.

Pasternak AL, et al. Establishment of a pharmacogenetics service focused on optimizing existing pharmacogenetic testing at a large academic health center. J Pers Med. 2020;10(4):1–10. https://doi.org/10.3390/jpm10040154.

Article  Google Scholar 

Martin MA, Klein TE, Dong BJ, Pirmohamed M, Haas DW, Kroetz DL. Clinical pharmacogenetics implementation consortium guidelines for HLA-B genotype and abacavir dosing. Clin Pharmacol Ther. 2012;91(4):734–8. https://doi.org/10.1038/clpt.2011.355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hershfield MS, et al. Clinical pharmacogenetics implementation consortium guidelines for human leukocyte antigen-b genotype and allopurinol dosing. Clin Pharmacol Ther. 2013;93(2):153–8. https://doi.org/10.1038/clpt.2012.209.

Article  CAS  PubMed  Google Scholar 

Caudle KE et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing, Clin Pharmacol Ther. 2014;9(5):542–8. Nature Publishing Group. https://doi.org/10.1038/clpt.2014.159.

Slight SP, et al. A cross-sectional observational study of high override rates of drug allergy alerts in inpatient and outpatient settings, and opportunities for improvement. BMJ Qual Saf. 2017;26(3):217–25. https://doi.org/10.1136/bmjqs-2015-004851.

Article  PubMed  Google Scholar 

Blumenthal KG, Park MA, Macy EM. Redesigning the allergy module of the electronic health record. Ann Allergy Asthma Immunol. 2016;117(2):126–31. https://doi.org/10.1016/j.anai.2016.05.017.

Article  PubMed  Google Scholar 

Goss FR, et al. A value set for documenting adverse reactions in electronic health records. J Am Med Inform Assoc. 2018;25(6):661–9. https://doi.org/10.1093/jamia/ocx139.

Article  PubMed  Google Scholar 

Rukasin CRF, Henderlight S, Bosen T, Nelson SD, Phillips EJ. Implications of electronic health record transition on drug allergy labels. J Allergy Clin Immunol. In Pract. 2020;8(2):764–6. https://doi.org/10.1016/j.jaip.2019.07.017.

Alvarez-Arango S, et al. Vancomycin hypersensitivity reactions documented in electronic health records. J Allergy Clin Immunol. In Pract. 2021;9(2):906–12. https://doi.org/10.1016/j.jaip.2020.09.027.

Shah NS, Ridgway JP, Pettit N, Fahrenbach J, Robicsek A. Documenting penicillin allergy: the impact of inconsistency. PLoS One. 11(3). https://doi.org/10.1371/journal.pone.0150514.

Lyons N, Rankin S, Sarangarm P, Washington C, Weiss SJ, Ernst AA. Disparity in patients’ self-reported and charted medication allergy information. South Med J. 2015;108(6):332–6. https://doi.org/10.14423/SMJ.0000000000000301.

Article  PubMed  Google Scholar 

Cavallari LH, et al. Institutional profile: University of Florida health personalized medicine program. Pharmacogenomics. 2017;18(5):421–6. https://doi.org/10.2217/pgs-2017-0028.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hertz DL, et al. Institutional profile of pharmacogenetics within University of Michigan College of Pharmacy. Pharmacogenomics. 2017;18(12). https://doi.org/10.2217/pgs-2017-0107.

Hoffman JM, et al. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet. 2014;166(1):45–55. https://doi.org/10.1002/ajmg.c.31391.

Article  Google Scholar 

Dunnenberger HM, et al. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. Am J Health Syst Pharm. 2016;73(23):1956–66. https://doi.org/10.2146/ajhp160072.

Article  PubMed  Google Scholar 

Dolan ME, Maitland ML, O’Donnell PH, Nakamura Y, Cox NJ, Ratain MJ. Institutional profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science. Pharmacogenomics. 2013;14(12):1383–7. https://doi.org/10.2217/pgs.13.134.

Article  CAS  PubMed  Google Scholar 

Johansen Taber KA, Dickinson BD. Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties. Pharmacogenomics Pers Med. 2014;7(1):145–62. https://doi.org/10.2147/PGPM.S63715.

Article  Google Scholar 

Beitelshees AL, et al. Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection. Genet Med. 2020;22(11):1898–902. https://doi.org/10.1038/s41436-020-0894-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caudle KE, Keeling NJ, Klein TE, Whirl-Carrillo M, Pratt VM, Hoffman JM. Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward. Pharmacogenomics. Future Medicine Ltd. 2018;19(10):847–60. https://doi.org/10.2217/pgs-2018-0028.

Shakib S, Caughey GE, Fok JS, Smith B. Adverse drug reaction classification by health professionals: appropriate discrimination between allergy and intolerance? Clin Transl Allergy. 2019;9(1). https://doi.org/10.1186/s13601-019-0259-6.

Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES. The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis. 2018;66(3):329–36.

Article  PubMed  Google Scholar 

Inglis JM, Caughey GE, Smith W, Shakib S. Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels. Intern Med J. 2017;47(11):1292–7. https://doi.org/10.1111/imj.13558.

Article  PubMed  Google Scholar 

Gerace KS, Phillips E. Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract. 2015;3:815–6.

Article  PubMed  Google Scholar 

Ramsey A, Macy E, Chiriac AM, Blumenthal KG. Drug allergy labels lost in translation: from patient to charts and backwards, J Allergy Clin Immunol. In Pract. 2021;9(8):3015–20. https://doi.org/10.1016/j.jaip.2021.02.005.

Article  CAS  Google Scholar 

• Phadke NA, et al. Allergy safety events in health care: development and application of a classification schema based on retrospective review, J Allergy  Clin Immunol. In Pract. 2022;10(7):1844–55.e3. https://doi.org/10.1016/j.jaip.2022.03.026. Classification schema based on a retrospective review to identify failures that can cause allergy-related safety events. Findings suggest that using such a schema can help improve allergy safety practices by identifying areas for improvement.

Guyer AC, et al. Allergy electronic health record documentation: a 2022 work group report of the AAAAI adverse reactions to drugs, biologicals, and latex committee. J Allergy Clin Immunol. In Pract. 2022;10(11):2854–67. https://doi.org/10.1016/j.jaip.2022.08.020.

Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL. Role of computerized physician order entry systems in facilitating medication errors. JAMA. 2005;293(10):1197–203. https://doi.org/10.1001/jama.293.10.1197.

Article  CAS  PubMed  Google Scholar 

Campbell EM, Sittig DF, Ash JS, Guappone KP, Dykstra RH. Types of unintended consequences related to computerized provider order entry. J Am Med Inform Assoc. 2006;13(5):547–56. https://doi.org/10.1197/jamia.M2042.

Article  PubMed  PubMed Central  Google Scholar 

Topaz M, et al. Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience. J Am Med Inform Assoc. 2016;23(3):601–8. https://doi.org/10.1093/jamia/ocv143.

Article  PubMed  Google Scholar 

Joyner LM, Alicea LA, Goldman JL, Suppes SL, Tillman EM. Methods for detecting pediatric adverse drug reactions from the electronic medical record. J Clin Pharmacol. 2021;61(11):1479–84. https://doi.org/10.1002/jcph.1916.

Article  CAS  PubMed  Google Scholar 

• Wang L, Park H, Vallamkonda S, Seger DL, Blackley SV, Garabedian PM, Goss F, Blumenthal KG, Bates DW, Murphy S, Zhou L. Dynamic reaction picklist for improving allergy reaction documentation: a usability study. Int J Med Informatics. 2023;1(170):104939. The novel dynamic reaction picklist is a promising solution to improve drug allergy documentation in EHRs by reducing the use of free-text entries and decreasing the time required for documentation. This new approach can potentially address some of the challenges associated with drug allergy documentation in EHRs.

Goss FR, et al. Evaluating standard terminologies for encoding allergy information. J Am Med Inform Assoc. 2013;20(5):969–79. https://doi.org/10.1136/amiajnl-2012-000816.

Article  PubMed  PubMed Central  Google Scholar 

Siegersma KR, Evers M, Bots SH, Groepenhoff F, Appelman Y, Hofstra L, Tulevski II, Somsen GA, den Ruijter HM, Spruit M, Onland-Moret NC. Development of a pipeline for adverse drug reaction identification in clinical notes: word embedding models and string matching. JMIR Med Inform. 2022;10(1):e31063. https://doi.org/10.2196/31063. PMID: 35076407; PMCID: PMC8826143.

Hicks JK, Dunnenberger HM, Gumpper KF, Haidar CE, Hoffman JM. Integrating pharmacogenomics into electronic health records with clinical decision support. Am J Health Syst Pharm. 2016;73(23):1967–76. https://doi.org/10.2146/ajhp160030.

Article  PubMed  Google Scholar 

Hoffman JM, et al. Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC). J Am Med Inform Assoc. 2016;23(4):796–801. https://doi.org/10.1093/jamia/ocw027.

Article  PubMed  PubMed Central  Google Scholar 

Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL. Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther. 2008;84(3):326–31. https://doi.org/10.1038/clpt.2008.10. Epub 2008 Feb 27. Erratum in: Clin Pharmacol Ther. 84(3):430. PMID: 18305455; PMCID: PMC2683977.

Obeng AO, Kaszemacher T, Abul-Husn NS, Gottesman O, Vega A, Waite E, Myers K, Cho J, Bottinger EP, Ellis SB, Scott SA. Implementing algorithm-guided warfarin dosing in an ethnically diverse patient population using electronic health records and preemptive CYP2C9 and VKORC1 genetic testing. Clin Pharmacol Ther. 2016;100(5):427–30. https://doi.org/10.1002/cpt.425. Epub 2016 Aug 18. PMID: 27393744; PMCID: PMC5638436.

Van Driest SL, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharmacol Ther. 2014;95(4):423–31. https://doi.org/10.1038/clpt.2013.229.

Article  CAS  PubMed  Google Scholar 

Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296(9):1086–93. https://doi.org/10.1001/jama.296.9.1086.

A